HomeLIXTW • NASDAQ
add
Lixte Biotechnology
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 983.26K | -4.00% |
Net income | -986.03K | 3.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64M | -67.92% |
Total assets | 1.70M | -67.60% |
Total liabilities | 328.96K | 5.52% |
Total equity | 1.37M | — |
Shares outstanding | 2.25M | — |
Price to book | -0.04 | — |
Return on assets | -112.67% | — |
Return on capital | -136.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -986.03K | 3.21% |
Cash from operations | -957.60K | -1.40% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -957.60K | -143.67% |
Free cash flow | -686.66K | -21.33% |
About
Founded
2005
Website
Employees
3
